Bringing the fundamentals into focus…
Back to Supernus Pharmaceuticals, Inc.
How Supernus Pharmaceuticals, Inc. stacks up
SUPN · against 437 other Healthcare companies of similar size
Profitability
28/ 100
Near the bottom of its peers.
Ranked #334 of 438 · scores higher than 23% of peers
Bars: peers in each 10-point band of the profitability score34 peers with a profitability score of 20–29, including SUPN · Click a bar to see the companies
Why profitability scores 28?
Weighted metrics compared with all Healthcare companies.Mainly because of its operating margin, return on invested capital and return on assets, which are weaker than most Healthcare peers.
- a thinner operating margin: weaker than 77% of peers. Operating margin: -15.7% vs peer median 7.1%
- a lower return on invested capital: weaker than 75% of peers. Return on invested capital: -12.1% vs peer median 4.7%
- a lower return on assets: weaker than 73% of peers. Return on assets: -7.7% vs peer median 1.7%
Metric by metric
Position: dot = SUPN, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | SUPN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 413 reported | -12.1% | 5.4% | 20% | 33% | |
| Operating marginHigher is better · 410 reported | -15.7% | 7.0% | 20% | 33% | |
| Return on assetsHigher is better · 422 reported | -7.7% | 1.9% | 22% | 33% | |
| Return on equityHigher is better · 406 reported | -10.5% | 4.1% | 26% | Context only | |
| Gross marginHigher is better · 453 reported | 72.9% | 47.4% | 81% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around SUPN| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 3 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 3 | 11.2B DKK (≈$1.7B) | 99 | 59 | |
| 3 | 51.3B ZAR (≈$2.8B) | 99 | 73 | |
| 331 | 1.8B USD | 29 | 31 | |
| 334 | 15.4B HKD (≈$2.0B) | 28 | 44 | |
| 334 | 1.2B USD | 28 | 36 | |
| 334 | 1.1B USD | 28 | 50 | |
| 334 | 1.6B USD | 28 | 48 | |
| 338 | 143.9B JPY (≈$978M) | 27 | 26 | |
| 338 | 7.4B CNY (≈$1.0B) | 27 | 34 | |
| 338 | 1.6B USD | 27 | 33 | |
| 338 | 1.8B AUD (≈$1.2B) | 27 | 41 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score